Physician profile
Rastislav Kucinsky
NPI 1174787113
$4,075.93
in general payments reported to CMS, 2019-2025
30 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,343 · 2020: $436 · 2021: $399 · 2022: $375 · 2023: $445 · 2024: $569 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,523.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $611.28 | 2020-2025 | Impella |
| Abbott Laboratories | $485.31 | 2019-2025 | Jot Dx, Optis, Tendril |
| Philips North America LLC | $369.47 | 2019-2024 | (6571) Eagle Eye |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $323.58 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $281.68 | 2021-2025 | Versacross Access Solution, Ingevity+, General - Vascular Intervention |
| Janssen Pharmaceuticals, INC | $231.24 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $197.60 | 2019-2020 | |
| Shockwave Medical, INC | $195.23 | 2019-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $185.74 | 2023-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Astrazeneca Pharmaceuticals LP | $165.78 | 2019-2023 | |
| Pfizer INC. | $138.45 | 2019-2020 | |
| Inari Medical, INC. | $129.58 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Regeneron Healthcare Solutions, INC. | $118.73 | 2019 | |
| Amgen INC. | $88.43 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $79.66 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $67.73 | 2019-2021 | |
| Penumbra, INC. | $56.55 | 2022-2025 | Indigo System, Penumbra System |
| Terumo Medical Corporation | $43.48 | 2022-2023 | Metacross Otw |
| Teleflex LLC | $37.22 | 2019-2023 | Guideliner |
| Siemens Medical Solutions USA, INC. | $36.82 | 2021 | |
| Angiodynamics, INC. | $36.72 | 2024 | Alphavac |
| Biotronik INC. | $34.20 | 2019-2021 | |
| Actelion Pharmaceuticals US, INC. | $32.78 | 2019 | |
| Irhythm Technologies, INC. | $29.04 | 2024 | Zio Monitor, Zio Xt Patch |
| Change Healthcare Technologies, LLC | $20.00 | 2023 | Change Healthcare Cardiology |
| Amarin Pharma, INC. | $19.27 | 2019 | |
| Ekos Corporation | $17.93 | 2019 | |
| Sanofi-Aventis U.S. LLC | $16.56 | 2019 | |
| Medtronic Vascular, INC. | $13.92 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rastislav Kucinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.